Correlation Between BioGaia AB and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both BioGaia AB and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioGaia AB and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioGaia AB and Enorama Pharma AB, you can compare the effects of market volatilities on BioGaia AB and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioGaia AB with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioGaia AB and Enorama Pharma.
Diversification Opportunities for BioGaia AB and Enorama Pharma
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between BioGaia and Enorama is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding BioGaia AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and BioGaia AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioGaia AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of BioGaia AB i.e., BioGaia AB and Enorama Pharma go up and down completely randomly.
Pair Corralation between BioGaia AB and Enorama Pharma
Assuming the 90 days trading horizon BioGaia AB is expected to generate 4.45 times less return on investment than Enorama Pharma. But when comparing it to its historical volatility, BioGaia AB is 4.3 times less risky than Enorama Pharma. It trades about 0.03 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 419.00 in Enorama Pharma AB on August 29, 2024 and sell it today you would lose (58.00) from holding Enorama Pharma AB or give up 13.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioGaia AB vs. Enorama Pharma AB
Performance |
| Timeline |
| BioGaia AB |
| Enorama Pharma AB |
BioGaia AB and Enorama Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioGaia AB and Enorama Pharma
The main advantage of trading using opposite BioGaia AB and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioGaia AB position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.| BioGaia AB vs. Biotage AB | BioGaia AB vs. CellaVision AB | BioGaia AB vs. Sectra AB | BioGaia AB vs. Elekta AB |
| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |